Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announced technical ...
The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system As the first fully implantable device in the category, ...
DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today announced Dexcom Flex, a new CGM system ...
Zacks Investment Research on MSN
DXCM to launch Dexcom Flex CGM system for type 2 diabetes in Germany
DexCom DXCM recently announced the launch of Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for ...
PHC Holdings (OTCPK:PHCCF) and its subsidiary, Ascensia Diabetes Care, have signed a preliminary agreement to transfer the commercial operations for the Eversense Continuous Glucose Monitoring (CGM) ...
Credit: Ascensia Diabetes Care. Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management. The FDA has designated the Eversense 365 ...
During Dexcom Investor Day, CEO Jake Leach announced the company's newest CGM monitor, G8, which utilizes technology that ...
Please provide your email address to receive an email when new articles are posted on . The Tandem Mobi automated insulin delivery system can be integrated with ...
Continuous glucose monitoring (CGM) is no longer limited to type 1 diabetes (T1D) and may play a significant role in shaping the care of type 2 diabetes (T2D). Emerging evidence indicates that broader ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The Simplera CGM features a one-hand, two-step insertion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results